Companies: 10,795·Total market cap: $144.5T
Virbac S.A.

Virbac S.A.

VRBCFOTCHealthcare● Active
$431.80
+$23.80(+5.83%)
Market Cap$3.6B
P/E Ratio
52W High$431.8
52W Low$346

Virbac S.A. (VRBCF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

VRBCF · net income · updated Jun 9, 2026

Core profitability metrics

Net income was $150.8M for FY2025 (fiscal year ending 2025-12-31), up 3.8% year-over-year. Net profit margin was 10.3%. Based on available data, Virbac S.A. has been profitable since at least 2011.

FY2025 Net Income$150.8M▲ +3.8% YoY
Trailing 12M (TTM)$296.2Mtrailing 4 quarters sum
Net Profit Margin10.3%$150.8M ÷ $1.46B
YoY Change+3.8%
5-Year CAGR+2.1%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · VRBCF net income history · VRBCF profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$150.8M▲ +3.8%10.3%
FY2024$145.3M▲ +19.8%10.4%
FY2023$121.3M▼ 0.5%9.7%
FY2022$122.0M▲ +7.8%10.0%
FY2021$113.2M▼ 16.8%10.6%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Virbac S.A.
Virbac S.A.YOU
VRBCF
$150.8M+3.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Virbac S.A. (VRBCF) reported net income of $150.8M for FY2025 (fiscal year ending 2025-12-31), up 3.8% year-over-year. The net profit margin was 10.3% — meaning the company kept $0.10 of every dollar of revenue as profit.

Based on available data, Virbac S.A. has been profitable since at least 2011. Net income reached a peak of $150.8M in FY2025. Data available for 15 fiscal years.

Virbac S.A.'s net profit margin was 10.3% for FY2025, based on the latest annual results.

Investors sometimes search for "Virbac S.A. net worth" — the company's market capitalization is a separate figure from VRBCF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

VRBCF net income · 5 questions

Virbac S.A. is profitable. The company reported net income of $150.8M for FY2025, a net profit margin of 10.3%. Net income was up 3.8% year-over-year. Based on available data, Virbac S.A. has been profitable since at least 2011.

is VRBCF profitabledoes VRBCF make a profitVRBCF profitabilityVRBCF profitable company

Source: FMP /income-statement · GAAP · Virbac S.A. · Virbac S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026